Brevital Sodium
Active substance: methohexital
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · METHOHEXITAL SODIUM 500 mg/1
United StatesActive
Marketing holder: Par Health USA, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- METHOHEXITAL SODIUM · 500 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
Import and control
Control by country
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208d-01b0-7ea5-b308-3f31f9f87f28,01a1208f-4085-7ba1-8d4c-1db6c6edbd05,01a1209d-4f66-7942-bc77-b6c1216e5cc7;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42023-105
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- INTRAMUSCULAR, INTRAVENOUS, RECTAL
Sources
- product · openFDA NDC · 42023-105 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42023-105 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42023-105 · Verified 2026-10-09 · open in source